Modular Medical, INC Schedule 13G passive stakes
Filed when an investor crosses five percent without intending to seek control — the passive counterpart to a 13D.
NASDAQ
Solas Capital Management, LLC and Frederick Tucker Golden have reported beneficial ownership of approximately 9.99% of Modular Medical, Inc.'s common stock, primarily through investment funds and warrants.
NASDAQ
Bleichroeder LP, Bleichroeder Holdings LLC, and Andrew Gundlach have filed a Schedule 13G, reporting beneficial ownership of 6.23% of Modular Medical, Inc. common shares.
NASDAQ
Pathfinder Asset Management Limited has reported beneficial ownership of 399,775 shares, representing 7.4% of the common stock in Modular Medical, Inc., as of June 30, 2026.
NASDAQ
Solas Capital Management, LLC and Frederick Tucker Golden have reported beneficial ownership of 9.6% of Modular Medical, Inc.'s common stock, including shares issuable upon exercise of warrants.
NASDAQ
683 Capital Management, LLC, along with affiliated entities and individuals, has reported a beneficial ownership stake of 4.67% in Modular Medical, Inc. as of March 31, 2026.
NASDAQ
Bard Associates, Inc. has disclosed a beneficial ownership of 102,831 shares, representing 0.1% of the outstanding common stock of Modular Medical, Inc.
NASDAQ
AWM Investment Company, Inc. has filed a Schedule 13G reporting a 9.99% beneficial ownership stake in Modular Medical, Inc. common stock.
NASDAQ
Pathfinder Asset Management Ltd has disclosed a 6.43% beneficial ownership stake in Modular Medical, Inc., signaling institutional interest.
NASDAQ
Solas Capital Management and Frederick Tucker Golden have reported a 6.8% beneficial ownership stake in Modular Medical, Inc., primarily for investment purposes.
NASDAQ
683 Capital Management, LP, and Ari Zweiman have filed an amended Schedule 13G, reporting a 3.3% beneficial ownership in Modular Medical, Inc.
NASDAQ
Solas Capital Management, LLC and Frederick Tucker Golden have reported a 7.7% beneficial ownership stake in Modular Medical, Inc., comprising over 4.29 million shares.
NASDAQ
Alyeska Investment Group, Alyeska Fund GP, LLC, and Anand Parekh have disclosed a combined 3.81% beneficial ownership stake in Modular Medical, Inc.
NASDAQ
Bard Associates Inc. has reported a 5.6% beneficial ownership stake in Modular Medical, Inc., holding 2,910,219 shares of common stock.
NASDAQ
Alyeska Investment Group, L.P., along with Alyeska Fund GP, LLC and Anand Parekh, has disclosed a beneficial ownership of 5.48% in Modular Medical, Inc.'s common stock.
NASDAQ
Solas Capital Management, LLC and Frederick Tucker Golden have disclosed a beneficial ownership of 7.5% in Modular Medical, Inc., comprising over 4 million shares including warrants.
NASDAQ
SCHEDULE 13G/A: 683 Capital Management Amends Stake in Modular Medical, Disclosing 6.4% Beneficial Ownership
683 Capital Management, LLC, along with its affiliates, has filed an amendment to its Schedule 13G, disclosing a 6.4% beneficial ownership stake in Modular Medical, Inc. as of December 31, 2024.
NASDAQ
SCHEDULE 13G/A: Sio Capital Management Files Amended Schedule 13G, Disclosing Passive 0.73% Stake in Modular Medical, Inc.
Sio Capital Management, LLC has filed an Amendment No. 2 to its Schedule 13G, reporting a passive beneficial ownership of 251,990 shares, representing 0.73% of Modular Medical, Inc.'s common stock as of December 31, 2024.